Wolverine Trading, LLC Precigen, Inc. Put Options Transaction History

Wolverine Trading, LLC

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$0.91 - $1.88 $10,192 - $21,056	11,200 New	11,200 $10,000
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $58,598 - $91,300	16,600 Added 95.4%	34,000 $130,000
Q3 2021 Nov 12, 2021	SELL	$4.99 - $6.55 $22,954 - $30,130	-4,600 Reduced 20.91%	17,400 $88,000
Q2 2021 Aug 06, 2021	SELL	$6.24 - $8.22 $57,408 - $75,624	-9,200 Reduced 29.49%	22,000 $142,000
Q1 2021 May 14, 2021	SELL	$6.74 - $10.95 $158,390 - $257,324	-23,500 Reduced 42.96%	31,200 $210,000
Q4 2020 Feb 12, 2021	BUY	$3.75 - $10.56 $67,875 - $191,136	18,100 Added 49.45%	54,700 $544,000
Q3 2020 Nov 13, 2020	SELL	$3.5 - $6.2 $9,100 - $16,120	-2,600 Reduced 6.63%	36,600 $130,000
Q2 2020 Aug 13, 2020	BUY	$2.16 - $5.46 $84,672 - $214,032	39,200 New	39,200 $191,000

143

159M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $156M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.